VI. 論文業績一覧
VI-1.

一元化登録（2009年4月以降）データ利用申請・WG研究

論文業績
刊・号・
頁

業績
番号

54-7.

U1

2011

25(1):417.

U2

A suggested total size for the cord bloodbanks of Japan.
Successful cord blood transplantation in a
42-day-old boy with infantile Krabbedisease.
Allogeneic hematopoietic stem celltransplantation for acute myeloid leukemiawith t(6;9)(p23;q34) dramatically improves
the patient prognosis: a matched-pairanalysis.

Takanashi M, Tanaka H, Kohsaki M,
Bone Marrow
2011
Nakajima K, Tadokoro K, Nakabayashi M. Transplant46(7):101
4-5.

U3

Yagasaki H, Kato M, Ishige M, Shichino H,
Int J Hematol 2011
Chin M, Mugishima H.

93(4):566-8.

U4Ishiyama K, Takami A, Kanda Y, Nakao S,
Hidaka M, Maeda T, Naoe T, Taniguchi S,
Leukemia
Kawa K, Nagamura T, Atsuta Y, Sakamaki
H.

2012

26(3):461
-4.

U5

6

Prognostic factors for acute myeloid
leukemia patients with t(6;9)(p23;q34) who
underwent an allogeneic hematopoietic
stem cell transplant.

Ishiyama K, Takami A, Kanda Y, Nakao S,
Hidaka M, Maeda T, Naoe T, Taniguchi S,
Leukemia
Kawa K, Nagamura T, Tabuchi K, Atsuta
Y, Sakamaki H.

2012

26(6):141
6-9.

U6

7

Peripheral blood as a preferable source ofFuji S, Nakamura F, Hatanaka K,
stem cells for salvage transplantation in
Taniguchi S, Sato M, Mori S, Sakamaki H, Biol Bloodpatients with graft failure after cord blood
Yabe H, Miyamoto T, Kanamori H, Ueda Y, Marrowtransplantation: a retrospective analysis of
Kawa K, Kato K, Suzuki R, Atsuta Y,
Transplant
the registry data of the Japanese Society
Tamaki T, Kanda Y.
for Hematopoietic Cell Transplantation.

2012

18(9):140
7-14.

U7

2012

119(9):21
41-8.

U8

Blood

2012

119(10):2
409-16.

U9Biol Blood
Marrow
Transplant

論文タイトル

著者

小児へのさい帯血移植.

2

Pre-transplant imatinib-based therapy
Mizuta S, Matsuo K, Yagasaki F, Yujiri T,
improves the outcome of allogeneic
Hatta Y, Kimura Y, Ueda Y, Kanamori H,
hematopoietic stem cell transplantation for Usui N, Akiyama H, Miyazaki Y, Ohtake S, Leukemia
BCR-ABL-positive acute lymphoblastic
Atsuta Y, Sakamaki H, Kawa K, Morishima
leukemia.
Y, Ohnishi K, Naoe T, Ohno R.

4

5

Kanda J, Hishizawa M, Utsunomiya A,
Taniguchi S, Eto T, Moriuchi Y, Tanosaki
R, Kawano F, Miyazaki Y, Masuda M,
Nagafuji K, Hara M, Takanashi M, Kai S,
Blood
Atsuta Y, Suzuki R, Kawase T, Matsuo K,
Nagamura-Inoue T, Kato S, Sakamaki H,
Morishima Y, Okamura J, Ichinohe T,
Uchiyama T.

8Impact of graft-versus-host disease on
outcomes after allogeneic hematopoietic
cell transplantation for adult T-cellleukemia: a retrospective cohort study.

9

Kanda J, Saji H, Fukuda T, Kobayashi T,
Related transplantation with HLA-1 Ag
Miyamura K, Eto T, Kurokawa M,
mismatch in the GVH direction and HLAKanamori H, Mori T, Hidaka M, Iwato K,
8/8 allele-matched unrelated
Yoshida T, Sakamaki H, Tanaka J, Kawa
transplantation: a nationwide retrospective
K, Morishima Y, Suzuki R, Atsuta Y,
study.
Kanda Y.

発行
年

日本さい帯血バンクネットワーク設立10 2009
周年記念 そして明日から

1

3

加藤剛二.

雑誌名

Efficacy and long-term outcome oftreatment for pure red cell aplasia after
10
allogeneic stem cell transplantation frommajor ABO-incompatible donors.

Hirokawa M, Fukuda T, Ohashi K, Hidaka
M, Ichinohe T, Iwato K, Kanamori H,
Murata M, Sakura T, Imamura M, Adachi
S, Suzuki R, Morishima Y, Sakamaki H;
PRCA Collaborative Study Group.

2013

19(7):102
6-32.

U10

Changes in incidence and causes of nonrelapse mortality after allogeneic
hematopoietic cell transplantation in
11 patients with acuteleukemia/myelodysplastic syndrome: ananalysis of the Japan Transplant Outcome
Registry.

Kurosawa S, Yakushijin K, Yamaguchi T,
Atsuta Y, Nagamura-Inoue T, Akiyama H,
Taniguchi S, Miyamura K, Takahashi S,
Bone Marrow
2013
Eto T, Ogawa H, Kurokawa M, Tanaka J, Transplant
Kawa K, Kato K, Suzuki R, Morishima Y,
Sakamaki H, Fukuda T.

48(4):529
-36.

U11

発行
年

刊・号・
頁

業績
番号

Kurosawa S, Yakushijin K, Yamaguchi T,
Recent decrease in non-relapse mortality Atsuta Y, Nagamura-Inoue T, Akiyama H,
due to GVHD and infection after allogeneic Taniguchi S, Miyamura K, Takahashi S,
Bone Marrow
12
2013
hematopoietic cell transplantation in non- Eto T, Ogawa H, Kurokawa M, Tanaka J, Transplant
remission acute leukemia.
Kawa K, Kato K, Suzuki R, Morishima Y,
Sakamaki H, Fukuda T.

48(9):119
8-204.

U12

PBSCT is associated with poorer survival
and increased chronic GvHD than BMT in
13 Japanese paediatric patients with acuteleukaemia and an HLA-matched sibling
donor.

Shinzato A, Tabuchi K, Atsuta Y, Inoue M,
Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Pediatr Blood
2013
Kigasawa H, Kitoh T, Ogawa A, Takahashi Cancer
Y, Sasahara Y, Kato S, Adachi S.

60(9):151
3-9.

U13

Allogeneic hematopoietic stem cell
14 transplantation for intermediate
cytogenetic risk AML in first CR.

Imahashi N, Suzuki R, Fukuda T, Kakihana
K, Kanamori H, Eto T, Mori T, Kobayashi
N, Iwato K, Sakura T, Ikegame K,
Bone Marrow
2013
Kurokawa M, Kondo T, Iida H, Sakamaki Transplant
H, Tanaka J, Kawa K, Morishima Y, Atsuta
Y, Miyamura K.

48(1):5662.

U14

Int J Hematol 2013

98(2):223
-30.

U15

血液事業

35(4):703-5.

U16

Association between decreasing trend in
the mortality of adult T-cellleukemia/lymphoma and allogeneic
Chihara D, Ito H, Matsuda T, Katanoda K,
Blood Cancer
17 hematopoietic stem cell transplants in
Shibata A, Taniguchi S, Utsunomiya A,
2013
JJapan: analysis of Japanese vital statistics Sobue T, Matsuo K.
and Japan Society for Hematopoietic Cell
Transplantation (JSHCT).

3:e159.

U17

Granulocyte colony-stimulating factor
Konuma T, Ooi J, Uchida N, Ogawa H,
combined regimen in cord blood
Ohashi K, Kanamori H, Aotsuka N, Onishi
Haematologic
18 transplantation for acute myeloid leukemia: Y, Yamaguchi H, Kozai Y, Nagamura2014aa nationwide retrospective analysis inInoue T, Kato K, Suzuki R, Atsuta Y, KatoJapan.
S, Asano S, Takahashi S.

99(12):e2
64-8.

U18

Iida M, Fukuda T, Uchida N, Murata M,
Mycophenolate mofetil use after unrelated
Aotsuka N, Minagawa K, Oohashi K,
hematopoietic stem cell transplantation for
19
Fukushima K, Kondo T, Eto T, Miyamotoprophylaxis and treatment of graft-vs.T, Morishima Y, Nagamura T, Atsuta Y,
host disease in adult patients in Japan.
Suzuki R.

2014

28(9):980-9.

U19

Murata M, Nishida T, Taniguchi S, Ohashi
Allogeneic transplantation for primaryK, Ogawa H, Fukuda T, Mori T, Kobayashi
myelofibrosis with BM, peripheral blood orBone Marrow
20
H, Nakaseko C, Yamagata N, Morishima Y,
2014umbilical cord blood: an analysis of theTransplant
Nagamura-Inoue T, Sakamaki H, Atsuta Y,
JSHCT.
Suzuki R, Naoe T.

49(3):355
-60.

U20

Hematopoietic stem cell transplantation forinborn errors of metabolism: A report fromthe Research Committee on
Kato S, Yabe H, Takakura H, Mugishima
Transplantation for Inborn Errors of
H, Ishige M, Tanaka A, Kato K, Yoshida N, Pediatr
21
Metabolism of the Japanese Ministry of
Adachi S, Sakai N, Hashii Y, Ohashi T,
Transplant
Health, Labour and Welfare and the
Sasahara Y, Suzuki Y, Tabuchi K.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

20(2):203
-14.

U21

52(4):574-9.

U22

論文タイトル

著者

Feasibility of reduced-intensity
Sawada A, Ohga S, Ishii E, Inoue M,
conditioning followed by unrelated cord
Okada K, Inagaki J, Goto H, Suzuki N,
15 blood transplantation for primary
Koike K, Atsuta Y, Suzuki R, Yabe H,
hemophagocytic lymphohistiocytosis: a
Kawa K, Kato K, Yasutomo K.
nationwide retrospective analysis in Japan.
16

移植に必要なAB型の血漿・血小板製剤の永澤雅秀.
需給動向について.

雑誌名

Clin
Transplant

2013

2016

Kurita N, Gosho M, Yokoyama Y, Kato T,
Obara N, Sakata-Yanagimoto M,
A phase I/II trial of intrabone marrow cord
Hasegawa Y, Uchida N, Takahashi S,
blood transplantation and comparison ofBone Marrow
22
Kouzai Y, Atsuta Y, Kurata M, Ichinohe T,2017
the hematological recovery with theTransplant
Chiba S.
Japanese nationwide database.

雑誌名

発行
年

刊・号・
頁

業績
番号

Comparison of Conditioning with
Fludarabine/Busulfan and
23 Fludarabine/Melphalan in Allogeneic
Transplantation Recipients 50 Years or
Older.

Kawamura K, Kako S, Mizuta S, Ishiyama
K, Aoki J, Yano S, Fukuda T, Uchida N,
Biol Blood
Ozawa Y, Eto T, Iwato K, Kanamori H,
Marrow
Kahata K, Kondo T, Sawa M, Ichinohe T, Transplant
Atsuta Y, Kanda Y.

201723(12):20
79-87.

U23

Impact of a Low CD34+ Cell Dose on
24 Allogeneic Peripheral Blood Stem Cell
Transplantation.

Yamamoto C, Ogawa H, Fukuda T,
Biol Blood
Igarashi A, Okumura H, Uchida N, Hidaka
Marrow
M, Nakamae H, Matsuoka KI, Eto T,
Transplant
Ichinohe T, Atsuta Y, Kanda Y.

201824(4):708
-16.

U24

Impact of HIV Infection on Transplant
Outcomes after Autologous Peripheral
25 Blood Stem Cell Transplantation: A
Retrospective Study of Japanese Registry
Data.

Yoshinaga N, Kanda J, Aisa Y, Hagiwara
S, Mori T, Fukuda T, Ishida Y, Hashimoto Biol Blood
H, Iwato K, Kanda Y, Kurokawa M,
Marrow
Nakazawa H, Ota S, Uchida N, Ichinohe T, Transplant
Atsuta Y, Takaori-Kondo A.

201824(8):159
6-601.

U25

Yoshizato T, Dumitriu B, Hosokawa K,
Makishima H, Yoshida K, Townsley D,
Sato-Otsubo A, Sato Y, Liu D, Suzuki H,
Wu CO, Shiraishi Y, Clemente MJ,
Kataoka K, Shiozawa Y, Okuno Y, Chiba N Engl J Med 2015
K, Tanaka H, Nagata Y, Katagiri T, Kon A,
Sanada M, Scheinberg P, Miyano S,
Maciejewski JP, Nakao S, Young NS,
Ogawa S.

373(1):35
-47.

U26

Kako S, Fujiwara S, Sato M, Kimura SI,
Safety and Efficacy of Once-Daily
Nakasone H, Ohashi K, Kawakita T,
Biol Blood
27 Intravenous Busulfan in Allogeneic
Maeda T, Morishita T, Suzuki R, Fukuda Marrow
Transplantation: A Matched-Pair Analysis. T, Ichinohe T, Kurata M, Atsuta Y, Kanda TransplantY.

in press

U27

Impact of pretransplant leukemic blast% inbone marrow and peripheral blood on
Ogawa H, Ikegame K, Daimon T, Uchida N,
transplantation outcomes of patients with Fukuda T, Kakihana K, Eto T, Ozawa Y,
Bone Marrow
28
2018
acute myeloid leukemia undergoing
Kanamori H, Hidaka M, Iwato Y, Ichinohe Transplant
allogeneic stem cell transplantation in non- T, Takanashi M, Atsuta Y, Kanda Y.
CR.

53(4):478
-82.

U28

Kawajiri-Manako C, Sakaida E, Ohwada C,
Efficacy and Long-Term Outcomes ofMiyamoto T, Azuma T, Taguchi J, Mori T,
Biol Blood
Autologous Stem Cell Transplantation in
Hasegawa Y, Kondo T, Yujiri T,
29
Marrow
POEMS Syndrome: A Nationwide Survey in Yoshimitsu M, Imada K, Kurahashi S,
Transplant
Japan.
Kahata K, Ichinohe T, Hirokawa M, Atsuta
Y, Nakaseko C.

201824(6):118
0-6.

U29

2017

6(2):10814.

U30

2018

59(3):746-8.

U31

in press

U32

3(3):397405.

U33

論文タイトル

26

Somatic Mutations and Clonal
Hematopoiesis in Aplastic Anemia.

著者

折原勝己, 吾郷浩厚, 奥山美樹, 落合亮
日本造血細日本骨髄バンクドナーの2回骨髄提供に関 一, 澤 正史, 田野﨑隆二, 玉井佳子, 豊嶋
30
胞移植学会
する検討.
崇徳, 中尾康夫, 日野雅之, 宮﨑泰司, 神雑誌
田善伸, 金森平和.
Successful preemptive donor lymphocyte
Hirai M, Yagasaki H, Fujimura J, Inoue M,
infusions from a haploidentical donor in a
Leuk
31
Shimozawa K, Okuma H, Chin M,
boy with E2A-HLF-positive ALL.
Lymphoma
Takahashi S.
Prophylaxis and treatment withmycophenolate mofetil in children withgraft-versus-host disease undergoing32
allogeneic hematopoietic stem celltransplantation: a nationwide survey inJapan.

Kawashima N, Iida M, Suzuki R, Fukuda T,
Atsuta Y, Hashii Y, Inoue M, Kobayashi M,
Int J Hematol
Yabe H, Okada K, Adachi S, Yuza Y, Kawa
K, Kato K.

High probability of follow-up termination
33 among AYA survivors after allogeneic
hematopoietic cell transplantation.

Miyamura K, Yamashita T, Atsuta Y,
Ichinohe T, Kato K, Uchida N, Fukuda T,
Blood
Ohashi K, Ogawa H, Eto T, Inoue M,
Advances
Takahashi S, Mori T, Kanamori H, Yabe H,
Hama A, Okamoto S, Inamoto Y.

2019

発行
年

刊・号・
頁

業績
番号

Muramatsu H, Sakaguchi H, Taga T,
Tabuchi K, Adachi S, Inoue M, Kitoh T,
Suminoe A, Yabe H, Azuma E, Shioda Y, Pediatr Blood
2014
Ogawa A, Kinoshita A, Kigasawa H, Osugi Cancer
Y, Koike K, Kawa K, Kato K, Atsuta Y,
Kudo K.

61(5):925
-7.

WGP
1-1

Comparison of a fludarabine and melphalan
combination-based reduced toxicity
Ishida H, Adachi S, Hasegawa D, Okamoto
conditioning with myeloablative
Y, Goto H, Inagaki J, Inoue M, Koh K,
Pediatr Blood35
2015
conditioning by radiation and/or busulfan in Yabe H, Kawa K, Kato K, Atsuta Y, Kudo Cancer
acute myeloid leukemia in JapaneseK.
children and adolescents.

62(5):883
-9.

WGP
1-2

Comparison of Outcomes for PediatricPatients With Acute Myeloid Leukemia in
Remission and Undergoing Allogeneic
Hematopoietic Cell Transplantation With
36 Myeloablative Conditioning Regimens
Based on Either Intravenous Busulfan or
Total Body Irradiation: A Report From theJapanese Society for Hematopoietic Cell
Transplantation.

Ishida H, Kato M, Kudo K, Taga T,
Tomizawa D, Miyamura T, Goto H, Inagaki Biol Blood
J, Koh K, Terui K, Ogawa A, Kawano Y,
Marrow
Inoue M, Sawada A, Kato K, Atsuta Y,
Transplant
Yamashita T, Adachi S.

201521(12):21
41-7.

WGP
1-3

Role of Second Transplantation for
37 Children With Acute Myeloid Leukemia
Following Posttransplantation Relapse.

Taga T, Murakami Y, Tabuchi K, Adachi S,
Tomizawa D, Kojima Y, Kato K, Koike K, Pediatr Blood
2016
Koh K, Kajiwara R, Hamamoto K, Yabe H, Cancer
Kawa K, Atsuta Y, Kudo K.

63(4):701
-5.

WGP
1-4

23(9):151
5-22.

WGP
1-5

論文タイトルReduced intensity conditioning in
34 allogeneic stem cell transplantation for
AML with Down syndrome.

著者

Tomizawa D, Tanaka S, Kondo T, Hashii
Y, Arai Y, Kudo K, Taga T, Fukuda T,
Allogeneic Hematopoietic Stem Cell
Goto H, Inagaki J, Koh K, Ohashi K,
38 Transplantation for Adolescents and Young
Ozawa Y, Inoue M, Kato K,Tanaka J,
Adults with Acute Myeloid Leukemia.
Atsuta Y, Adachi S, Ishida H.

雑誌名

Biol Blood
Marrow
Transplant

2017

Allogeneic hematopoietic stem celltransplantation for children and
39 adolescents with high-risk cytogenetic
AML: distinctly poor outcomes of FUSERG-positive cases.

Tomizawa D, Yoshida M, Kondo T,
Miyamura T, Taga T, Adachi S, Koh K,
Noguchi M, Kakuda H, Watanabe K, Cho
Y, Fukuda T, Kato M, Shiba N, Goto H,
Okada K, Inoue M, Hashii Y, Atsuta Y,
Ishida H.

Bone Marrow
Transplantin press

WGP
1-6

Comparison of conditioning regimens forautologous stem cell transplantation in40
children with acute myeloid leukemia: A
nationwide retrospective study in Japan.

Sakaguchi H, Muramatsu H, Hasegawa D,
Kudo K, Ishida H, Yoshida N, Koh K,
Noguchi M, Shiba N, Tokimasa S, Fukuda
Pediatr Blood
T, Goto H, Miyamura T, Nakazawa Y,
CancerHashii Y, Inoue M, Atsuta Y; Pediatric
AML Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

in press

WGP
1-7

Okamoto Y, Kudo K, Tabuchi K, Tomizawa
Hematopoietic stem-cell transplantation in D, Taga T, Goto H, Yabe H, Nakazawa Y,
Bone Marrow
41 children with refractory acute myeloid
Koh K, Ikegame K, Yoshida N, Uchida N,
Transplantleukemia.
Watanabe K, Koga Y, Inoue M, Kato K,
Atsuta Y, Ishida H.

in press

WGP
1-8

Donor lymphocyte infusion for thetreatment of relapsed acute myeloid
leukemia after allogeneic hematopoietic
stem cell transplantation: a retrospective
42
analysis by the Adult Acute Myeloid
Leukemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.
43

Takami A, Yano S, Yokoyama H,
Kuwatsuka Y, Yamaguchi T, Kanda Y,
Morishima Y, Fukuda T, Miyazaki Y,
Nakamae H, Tanaka J, Atsuta Y,
Kanamori H.

Biol Blood
Marrow
Transplant2014

20(11):1785-90.

WGP
2-1

Outcome of allogeneic hematopoietic stem Aoki J, Ishiyama K, Taniguchi S, Fukuda
Biol Bloodcell transplantation for acute myeloid
T, Ohashi K, Ogawa H, Kanamori H, Eto T,
Marrow
leukemia patients with central nervous
Iwato K, Sakamaki H, Morishima Y,
Transplantsystem involvement.
Nagamura T, Atsuta Y, Takami A.

2014

20(12):20
29-33.

WGP
2-2

発行
年

刊・号・
頁

業績
番号

2015

126(3):41
5-22.

WGP
2-3

Arai Y, Aoki K, Takeda J, Kondo T, Eto T,
Clinical significance of high-dose
Ota S, Hashimoto H, Fukuda T, Ozawa Y,
cytarabine added to
Kanda Y, Kato C, Kurokawa M, Iwato K,
J Hematol
45 cyclophosphamide/total-body irradiation in Onizuka M, Ichinohe T, Atsuta Y, Takami
Oncolbone marrow or peripheral blood stem cell A ; AML and MDS Working Group oftransplantation for myeloid malignancy.
Japan Society for Hematopoietic Cell
Transplantation.

2015

8:102.

WGP
2-4

Impact of age on outcomes of allogeneic
hematopoietic stem cell transplantation
46 with reduced intensity conditioning inelderly patients with acute myeloid
leukemia.

2016

91(3):302
-7.

WGP
2-5

Bone Marrow
2016
Transplant51(4):604
-6.

WGP
2-6

Comparable outcomes between autologous Mizutani M, Hara M, Fujita H, Aoki J,
Bone Marrow
48 and allogeneic transplant for adult acute
Kanamori H, Ohashi K, Usuki K, Fukuda T,
2016
Transplantmyeloid leukemia in first CR.
Chou T, Tanaka J, Atsuta Y, Takami A.

51(5):645
-53.

WGP
2-7

Mori J, Ishiyama K, Yamaguchi T, Tanaka
Outcomes of allogeneic hematopoietic cell J, Uchida N, Kobayashi T, Fukuda T,
49 transplantation in patients withKanamori H, Miyamura K, Takahashi S,
Ann Hematol 2016biphenotypic acute leukemia.
Eto T, Hirokawa M, Mori S, Nagamura T,
Atsuta Y, Takami A.

95(2):295
-300.

WGP
2-8

2016

47:47-53.

WGP
2-9

論文タイトル

Efficiency of high-dose cytarabine added
44 to CY/TBI in cord blood transplantation
for myeloid malignancy.

著者

雑誌名

Arai Y, Takeda J, Aoki K, Kondo T,
Takahashi S, Onishi Y, Ozawa Y, Aotsuka
N, Kouzai Y, Nakamae H, Ota S, Nakaseko
C, Yamaguchi H, Kato K, Atsuta Y,
Blood
Takami A ; AML and MDS Working Groupof the Japan Society for Hematopoietic
Cell Transplantation.

Aoki J, Kanamori H, Tanaka M, Yamasaki
S, Fukuda T, Ogawa H, Iwato K, Ohashi K,
Am J
Okumura H, Onizuka M, Maesako Y,
Hematol
Teshima T, Kobayashi N, Morishima Y,
Hirokawa M, Atsuta Y, Yano S, Takami A.

Impact of low-dose TBI on outcomes of
Aoki J, Seo S, Kanamori H, Tanaka M,
reduced intensity conditioning allogeneic
Fukuda T, Onizuka M, Kobayashi N,
47
hematopoietic stem cell transplantation for Kondo T, Sawa M, Uchida N, Iwato K,
AML.
Icihnohe T, Atsuta Y, Yano S, Takami A.

Acute megakaryoblastic leukemia, unlike
acute erythroid leukemia, predicts an
50
unfavorable outcome after allogeneic
HSCT.

Ishiyama K, Yamaguchi T, Eto T, Ohashi
K, Uchida N, Kanamori H, Fukuda T,
Miyamura K, Inoue Y, Taguchi J, Mori T, Leuk Res
Iwato K, Morishima Y, Nagamura-Inoue T,
Atsuta Y, Sakamaki H, Takami A.

Role of reduced-intensity conditioning
allogeneic hematopoietic cell51
transplantation in older patients with denovo acute myeloid leukemia.

Yamasaki S, Hirakawa A, Aoki J, UchidaN, Fukuda T, Ogawa H, Ohashi K, Kondo
T, Eto T, Kanamori H, Okumura H, Iwato
K, Ichinohe T, Kanda J, Onizuka M,
Kuwatsuka Y, Yanada M, Atsuta Y,
Takami A, Yano S.

Ann Hematol 2017

96(2):289
-97.

WGP
2-10

Reduced-intensity conditioning allogeneic
hematopoietic cell transplantation for
52
younger patients with acute myeloid
leukemia: a registry-based study.

Yanada M, Kurosawa S, Kobayashi T,
Ozawa Y, Kanamori H, Kobayashi N, Sawa Bone Marrow
2017
M, Nakamae H, Uchida N, Hashimoto H,
Transplant
Fukuda T, Hirokawa M, Atsuta Y, Yano S.

52(6):818
-24.

WGP
2-11

Allogeneic Hematopoietic Cell
Transplantation for Leukemic
Transformation Preceded by Philadelphia
Chromosome-Negative Myeloproliferative
53
Neoplasms: A Nationwide Survey by the
Adult Acute Myeloid Leukemia Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Takagi S, Masuoka K, Uchida N, Kurokawa Biol Blood
M, Nakamae H, Imada K, Iwato K, Ichinohe Marrow
T, Atsuta Y, Takami A, Yano S.
Transplant22(12):22
08-13.

WGP
2-12

2016

発行
年

刊・号・
頁

業績
番号

Konuma T, Kondo T, Yamashita T, UchidaN, Fukuda T, Ozawa Y, Ohashi K, Ogawa
Outcome of allogeneic hematopoietic stem H, Kato C, Takahashi S, Kanamori H, Eto
cell transplantation in adult patients with T, Nakaseko C, Kohno A, Ichinohe T,
54
Ann Hematol 2017
acute myeloid leukemia harboring trisomy Atsuta Y, Takami A, Yano S; Adult Acute
8.
Myeloid Leukemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation (JSHCT).

96(3):469
-78.

WGP
2-13

Yanada M, Yano S, Kanamori H, Gotoh M,
Autologous hematopoietic cell
Emi N, Watakabe K, Kurokawa M,
transplantation for acute promyelocytic
Nishikawa A, Mori T, Tomita N, Murata M, Leuk
55 leukemia in second complete remission:
Hashimoto H, Henzan H, Kanda Y, Sawa Lymphoma
outcomes before and after the introduction
M, Kohno A, Atsuta Y, Ichinohe T, Takami
of arsenic trioxide.
A.

2017

58(5):106
1-7.

WGP
2-14

2017

23(8):139
8-404.

WGP
2-15

2018

59(3):601
-9.

WGP
2-16

103(2):e6
9-72.

WGP
2-17

2017

23(9):144
7-54.

WGP
2-18

2018

182(2):24
5-50.

WGP
2-19

Konuma T, Mizuno S, Kondo T,
Yamaguchi H, Fukuda T, Uchida N, Najima
Y, Kanamori H, Ota S, Nakamae H,
Nakamae M, Mizuno I, Sugita J, Onishi Y,
Yokota A, Takahashi S, Kanda Y, Ichinohe Ann Hematol 2018
T, Atsuta Y, Yano S; Adult Acute Myeloid
Leukemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation (JSHCT).

97(11):2173-83.

WGP
2-20

Yanada m,Masuko M,Mori J,Aoki J,Mizuno
S,Fukuda T,Kakihana K,Ozawa Y,ota
Bone Marrow
S,Kannamori H,Mori T,Nakamae H,Eto
TransplantT,Shiratori S,Maeda T,Iwato K,Ichinohe
T,Kanda Y,Tanaka J,Atsuta Y,Yano S.

in press

WGP
2-21

論文タイトルOutcomes of Allogeneic Hematopoietic
Cell Transplantation in Acute Myeloid
56
Leukemia Patients with Abnormalities of
the Short Arm of Chromosome 17.
Effect of cytogenetic risk status on
outcomes for patients with acute myeloid
leukemia undergoing various types of57
allogeneic hematopoietic celltransplantation: an analysis of 7812
patients.
Outcomes after allogeneic hematopoietic
stem cell transplantation in patients with
58
acute myeloid leukemia harboringt(7;11)(p15;p15).

Comparison of Autologous and Unrelated
59 Transplants for Cytogenetically Normal
Acute Myelogenous Leukemia.

Allogeneic haematopoietic celltransplantation for adult acute myeloid
leukaemia in second remission: a
60 retrospective study of the Adult Acute
Myeloid Leukaemia Working Group of theJapan Society for Haematopoietic Cell
Transplantation (JSHCT).
Allogeneic hematopoietic celltransplantation in adult acute myeloid
leukemia with 11q23 abnormality: aretrospective study of the Adult Acute
61
Myeloid Leukemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation (JSHCT).

Patients with acute myeloid leukemia
undergoing allogeneic hematopoietic cell
62
transplantation: trends in survival during
the past two decades.

著者

Mori J, Yanada M, Uchida N, Fukuda T,
Sakura T, Hidaka M, Watakabe-Inamoto
K, Kanamori H, Ogawa H, Ichinohe T,
Tanaka J, Atsuta Y, Yano S.

雑誌名Biol Blood
Marrow
Transplant

Yanada M, Mori J, Aoki J, Harada K,
Mizuno S, Uchida N, Kurosawa S, Toya T,
Kanamori H, Ozawa Y, Ogawa H, Henzan Leuk
H, Iwato K, Sakura T, Ota S, Fukuda T,
LymphomaIchinohe T, Atsuta Y, Yano S.

Harada K, Doki N, Aoki J, Mori J, Machida
S, Masuko M, Uchida N, Najima Y, Fukuda
T, Kanamori H, Ogawa H, Ota S, Ogawa K, Haematologic
2018
Takahashi S, Kasai M, Maeda A, Nagafuji a
K, Kawakita T, Ichinohe T, Atsuta Y.
Mizutani M, Takami A, Hara M, Mizuno S,
Yanada M, Chou T, Uchiyama H, Ohashi
K, Miyamoto T, Ozawa Y, Imataki O,
Biol Blood
Kobayashi N, Uchida N, Kanamori H,
Marrow
Kamimura T, Eto T, Onizuka M, Tanaka J, Transplant
Atsuta Y, Yano S.

Konuma T, Yanada M, Yamasaki S,
Kuwatsuka Y, Fukuda T, Kobayashi T,
Br J
Ozawa Y, Uchida N, Ota S, Hoshino T,
Haematol
Takahashi S, Kanda Y, Ueda Y, Takanashi
M, Kanda J, Ichinohe T, Atsuta Y, Yano S.

刊・号・
頁

業績
番号

in press

WGP
2-22

2019

25(1):2327.

WGP
2-23

2019

94(1):103
-110.

WGP
2-24

Kato M, Horikoshi Y, Okamoto Y,
Takahashi Y, Hasegawa D, Koh K, Takita
Bone Marrow
J, Inoue M, Kigasawa H, Ogawa A,
2012
Transplant
Sasahara Y, Kawa K, Yabe H, Sakamaki H,
Suzuki R, Kato K.

47(10):13
07-11.

WGP
3-1

Kato M, Takahashi Y, Tomizawa D,
Okamoto Y, Inagaki J, Koh K, Ogawa A,
Okada K, Cho Y, Takita J, Goto H,
Sakamaki H, Yabe H, Kawa K, Suzuki R,
Kudo K, Kato K.

2013

19(12):16
90-4.

WGP
3-2

2015

125(8):13
52-4.

WGP
3-3

Goto H, Kaneko T, Shioda Y, Kajiwara M,
Hematopoietic stem cell transplantation for
Sakashita K, Kitoh T, Hayakawa A, Miki M, Pediatr Blood69 patients with acute lymphoblastic leukemia
2015
Kato K, Ogawa A, Hashii Y, Inukai T, Kato Cancer
and Down syndrome.
C, Sakamaki H, Yabe H, Suzuki R, Kato K.

62(1):148
-52.

WGP
3-4

Allogeneic haematopoietic stem celltransplantation for infant acutelymphoblastic leukaemia with KMT2A
Kato M, Hasegawa D, Koh K, Kato K,(MLL) rearrangements: a retrospective
Takita J, Inagaki J, Yabe H, Goto H,
70
study from the paediatric acute
Adachi S, Hayakawa A, Takeshita Y,
lymphoblastic leukaemia working group of Sawada A, Atsuta Y, Kato K.
the Japan Society for Haematopoietic Cell
Transplantation.

Br J
Haematol

2015

168(4):56
4-70.

WGP
3-5

Comparison of chemotherapeutic agentsas a myeloablative conditioning with total
body irradiation for pediatric acute71 lymphoblastic leukemia: A study from thepediatric ALL working group of the Japan
Society for Hematopoietic Cell
Transplantation.

Kato M, Ishida H, Koh K, Inagaki J, Kato
K, Goto H, Kaneko T, Cho Y, Hashii Y,
Kurosawa H, Takita J, Hamamoto K,
Inoue M, Sawada A, Suzuki R, Kato K.

Pediatr Blood
2015
Cancer62(10):18
44-50.

WGP
3-6

Impact of graft-versus-host disease on
72 relapse and survival after allogeneic stem
cell transplantation for pediatric leukemia.

Kato M, Kurata M, Kanda J, Kato K,
Tomizawa D, Kudo K, Yoshida N,
Watanabe K, Shimada H, Inagaki J, Koh K, Bone Marrow
Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Transplant
Okada K, Inoue M, Hashii Y, Teshima T,
Murata M, Atsuta Y.

in press

WGP
3-7

論文タイトル著者

雑誌名

Prognostic impact of melphalan dose andtotal body irradiation use in patients with63 acute myeloid leukemia undergoing
allogeneic stem cell transplantation with
reduced-intensity conditioning.

Harada K, Yanada M, Machida S,
Kanamori H, Onizuka M, Ozawa Y,
Leuk
Kobayashi H, Sawa M, Katayama Y,
Lymphoma
Ohashi K, Kanda J, Ichinohe T, Atsuta Y,
Yano S.

Hematopoietic Cell Transplantation for
64 Acute Panmyelosis with Myelofibrosis: A
Retrospective Study in Japan.

Konuma T, Kondo T, Kawata T, Iwato K3,
Sato Y, Mori T, Ohashi K, Nakazawa H,
Sugahara H, Ago H, Eto T, Imamura Y,
Biol Blood
Fukuda T, Kanda Y, Atsuta Y, Yano S;
Marrow
Adult Acute Myeloid Leukemia Working
TransplantGroup of the Japan Society for
Hematopoietic Cell Transplantation.

Konuma T, Harada K, Yamasaki S, Mizuno
Upfront allogeneic hematopoietic cell
S, Uchida N, Takahashi S, Onizuka M,
transplantation (HCT) versus remission
Nakamae H, Hidaka M, Fukuda T, Ohashi
induction chemotherapy followed byK, Kohno A, Matsushita A, Kanamori H,
Am J
65
allogeneic HCT for acute myeloid leukemia Ashida T, Kanda J, Atsuta Y, Yano S;
Hematolwith multilineage dysplasia: A propensity
Adult Acute Myeloid Leukemia Working
score matched analysis.
Group of the Japan Society for
Hematopoietic Cell Transplantation.

66

Second allogeneic hematopoietic SCT for
relapsed ALL in children.

Comparison of intravenous with oral
busulfan in allogeneic hematopoietic stem
67 cell transplantation with myeloablative
conditioning regimens for pediatric acuteleukemia.

Biol Blood
Marrow
Transplant

Kato K, Kato M, Hasegawa D, Kawasaki H,
Comparison of transplantation with
Ishida H, Okamoto Y, Koh K, Inoue M,
68 reduced and myeloablative conditioning for
Blood
Inagaki J, Kato K, Sakamaki H, Yabe H,
children with acute lymphoblastic leukemia.
Kawa K, Suzuki R, Atsuta Y.

発行
年

論文タイトル

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

Reduced-intensity allogeneic stem celltransplantation for patients aged 50 years
or older with B-cell ALL in remission: a73
retrospective study by the Adult ALL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

Kanamori H, Mizuta S, Kako S, Kato H,
Nishiwaki S, Imai K, Shigematsu A,
Nakamae H, Tanaka M, Ikegame K, Yujiri
T, Fukuda T, Minagawa K, Eto T,
Nagamura-Inoue T, Morishima Y, Suzuki
R, Sakamaki H, Tanaka J.

Bone Marrow
2013
Transplant

48(12):15
13-8.

WGP
4-1

Impact of a donor source on adult
Philadelphia chromosome-negative acutelymphoblastic leukemia: a retrospective
74 analysis from the Adult Acute
Lymphoblastic Leukemia Working Group of
the Japan Society for Hematopoietic Cell
Transplantation.

Nishiwaki S, Miyamura K, Ohashi K,
Kurokawa M, Taniguchi S, Fukuda T,
Ikegame K, Takahashi S, Mori T, Imai K,
Iida H, Hidaka M, Sakamaki H, Morishima
Y, Kato K, Suzuki R, Tanaka J; Adult
Acute Lymphoblastic Leukemia Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Ann Oncol

201324(6):159
4-602.

WGP
4-2

Reduced-intensity vs myeloablative
conditioning allogeneic hematopoietic SCT
for patients aged over 45 years with ALL
75 in remission: a study from the Adult ALL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

Tanaka J, Kanamori H, Nishiwaki S,
Ohashi K, Taniguchi S, Eto T, Nakamae H,
Bone Marrow
Minagawa K, Miyamura K, Sakamaki H,
2013
Transplant
Morishima Y, Kato K, Suzuki R, Nishimoto
N, Oba K, Masauzi N.

48(11):13
89-94.

WGP
4-3

99(11):e228-30.

WGP
4-4

2014

123(15):2
325-32.

WGP
4-5

Nishiwaki S, Imai K, Mizuta S, Kanamori H,
Impact of MRD and TKI on allogeneic
Ohashi K, Fukuda T, Onishi Y, Takahashi
hematopoietic cell transplantation forBone Marrow
78
S, Uchida N, Eto T, Nakamae H, Yujiri T,
2016
Ph+ALL: a study from the adult ALL WG of
TransplantMori S, Nagamura-Inoue T, Suzuki R,
the JSHCT.
Atsuta Y, Tanaka J.

51(1):4350.

WGP
4-6

Mitsuhashi K, Kako S, Shigematsu A,
Comparison of Cyclophosphamide
Atsuta Y, Doki N, Fukuda T, Kanamori H,
Combined with Total Body Irradiation, Oral Onizuka M, Takahashi S, Ozawa Y,
Biol Blood
Busulfan, or Intravenous Busulfan for
Kurokawa M, Inoue Y, Nagamura-Inoue T,
79
Marrow
Allogeneic Hematopoietic Cell
Morishima Y, Mizuta S, Tanaka J; Adult
Transplant
Transplantation in Adults with Acute
Acute Lymphoblastic Leukemia Working
Lymphoblastic Leukemia.
Group of the Japan Society for
Hematopoietic Cell Transplantation.

2016

22(12):21
94-200.

WGP
4-7

Arai Y, Kondo T, Shigematsu A, Tanaka J,
Takahashi S, Kobayashi T, Uchida N,
Bone Marrow
Onishi Y, Ishikawa J, Kanamori H, Sawa
2016
Transplant
M, Yokota A, Kouzai Y, Takanashi M,
Ichinohe T, Atsuta Y, Mizuta S.

51(12):16
36-9.

WGP
4-8

178(1):10
6-11.

WGP
4-9

Kato H, Kawase T, Kako S, Mizuta S,
Kurokawa M, Mori T, Ohashi K, Iwato K,
Analysis of outcomes following autologous
Miyamura K, Hidaka M, Sakamaki H,
stem-cell transplantation in adult patientsSuzuki R, Morishima Y, Tanaka J; Adult76 with Philadelphia chromosome-negative
Acute Lymphoblastic Leukemia Working
acute lymphoblastic leukemia during theGroup of Japan Society forfirst complete remission.
Hematopoietic Cell Transplantation(JSHCT).

Haematologic
2014aMizuta S, Matsuo K, Nishiwaki S, Imai K,
Pretransplant administration of imatinib for Kanamori H, Ohashi K, Fukuda T, Onishi
77 allo-HSCT in patients with BCR-ABLY, Miyamura K, Takahashi S, Onizuka M, Blood
positive acute lymphoblastic leukemia.
Atsuta Y, Suzuki R, Morishima Y, Kato K,
Sakamaki H, Tanaka J.

High-dose cytarabine added to CY/TBI
improves the prognosis of cord blood
80 transplantation for acute lymphoblastic
leukemia in adults: a retrospective cohort
study.
Increased non-relapse mortality due tohigh-dose cytarabine plus CY/TBI in
81
BMT/PBSCT for acute lymphoblastic
leukaemia in adults.

Arai Y, Kondo T, Shigematsu A, Tanaka J,
Ohashi K, Fukuda T, Kawakita T, Mori T,
Hoshino T, Onizuka M, Ozawa Y, Yoshida
Br J
S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S;
Haematol
Japan Society for Haematopoietic Cell
Transplantation.

2017論文タイトル
Allogeneic stem cell transplantation for
adult patients with acute lymphoblastic
leukemia who had central nervous system
82
involvement: a study from the Adult ALL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

105(6):80
5-11.

WGP
4-10

2018

93(1):4757.

WGP
4-11

Shigematsu A, Kako S, Mitsuhashi K,
Iwato K, Uchida N, Kanda Y, Fukuda T,
Sawa M, Senoo Y, Ogawa H, Miyamura K,
Takada S, Nagamura-Inoue T, Morishima Int J Hematol 2017
Y, Ichinohe T, Atsuta Y, Mizuta S, Tanaka
J.

Arai Y, Kondo T, Shigematsu A, Tanaka J,
Ohashi K, Fukuda T, Hidaka M, Kobayashi
Improved prognosis with additionalN, Iwato K, Sakura T, Onizuka M, Ozawa
medium-dose VP16 to CY/TBI in
Am J
83Y, Eto T, Kurokawa M, Kahata K, Uchidaallogeneic transplantation for high risk ALL
Hematol
N, Atsuta Y, Mizuta S, Kako S.
in adults.

Additional Cytogenetic Abnormalities with
Philadelphia Chromosome-Positive Acute84 Lymphoblastic Leukemia on Allogeneic
Stem Cell Transplantation in the Tyrosine
Kinase Inhibitor Era.

Akahoshi Y, Mizuta S, Shimizu H, UchidaN, Fukuda T, Kanamori H, Onizuka M,
Ozawa Y, Ohashi K, Ohta S, Eto T,
Biol Blood
Tanaka J, Atsuta Y, Kako S; Adult Acute Marrow
Lymphoblastic Leukemia Working Group Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

201824(10):20
09-16.

WGP
4-12

Effect of graft sources on allogeneic
hematopoietic stem cell transplantation
outcome in adults with chronic myeloid
85 leukemia in the era of tyrosine kinase
inhibitors: a Japanese Society of
Hematopoietic Cell Transplantation
retrospective analysis.

Ohashi K, Nagamura-Inoue T, Nagamura
F, Tojo A, Miyamura K, Mori T, Kurokawa
Int J Hematol 2014
M, Taniguchi S, Ishikawa J, Morishima Y,
Atsuta Y, Sakamaki H.

100(3):29
6-306.

WGP
6-1

Clinical impact of pretransplant use ofmultiple tyrosine kinase inhibitors on the
86 outcome of allogeneic hematopoietic stem
cell transplantation for chronic
myelogenous leukemia.

Kondo T, Nagamura-Inoue T, Tojo A,
Nagamura F, Uchida N, Nakamae H,
Fukuda T, Mori T, Yano S, Kurokawa M,
Ueno H, Kanamori H, Hashimoto H,
Onizuka M, Takanashi M, Ichinohe T,
Atsuta Y, Ohashi K.

Am J
Hematol

2017

92(9):902
-8.

WGP
6-2

Allogeneic hematopoietic stem cell
Itonaga H, Ota S, Ikeda T, Taji H, Amanotransplantation for the treatment of BCRI, Hasegawa Y, Ichinohe T, Fukuda T,
87 ABL1-negative atypical chronic myeloid
Leuk Res
Atsuta Y, Tanizawa A, Kondo T, Miyazaki
leukemia and chronic neutrophil leukemia:Y.
A retrospective nationwide study in Japan.

2018

75:50-7.

WGP
6-3

Pediatr Blood
2014
Cancer61(10):18
60-6.

WGP
7-1

Salvage allogeneic stem celltransplantation in patients with pediatric88
myelodysplastic syndrome andmyeloproliferative neoplasms.

Kato M, Yoshida N, Inagaki J, Maeba H,
Kudo K, Cho Y, Kurosawa H, Okimoto Y,
Tauchi H, Yabe H, Sawada A, Kato K,
Atsuta Y, Watanabe K.

Allogeneic haematopoietic celltransplantation with reduced-intensity
89 conditioning for elderly patients withadvanced myelodysplastic syndromes: anationwide study.

Aoki K , Ishikawa T, Ishiyama K, Aoki J,
Itonaga H, Fukuda T, Kakihana K, UchidaN, Ueda Y, Eto T, Mori T, Kondo T, Iwato
K, Morishima Y, Tanaka J, Atsuta Y,
Br J
Miyazaki Y; Adult Myelodysplastic
Haematol
Syndromes Working Group of the Japan
Society for Hematopoietic Cell
Transplantation (JSHCT).

2015

168(3):46
3-6.

WGP
8-1

Konuma T, Takahashi S, Uchida N,
Kuwatsuka Y, Yamasaki S, Aoki J, Onishi
Y, Aotsuka N, Ohashi K, Mori T, Masuko
Effect of Granulocyte Colony-Stimulating
M, Nakamae H, Miyamura K, Kato K,
Factor-Combined Conditioning in Cord
Biol Blood
Atsuta Y, Kato S, Asano S, Takami A,
90 Blood Transplantation for Myelodysplastic
Marrow
Miyazaki Y; Adult Myelodysplastic
Syndrome and Secondary Acute Myeloid
Transplant
Syndrome and Adult Acute Myeloid
Leukemia: A Retrospective Study in Japan.
Leukemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

201521(9):163
2-40.

WGP
8-2

雑誌名

発行
年

刊・号・
頁

業績
番号

Impacts of graft-versus-host disease on
outcomes after allogeneic hematopoietic
91 stem cell transplantation for chronic
myelomonocytic leukemia: A nationwide
retrospective study.

Itonaga H, Iwanaga M, Aoki K, Aoki J,
Ishiyama K, Ishikawa T, Sakura T, Fukuda
T, Najima Y, Yujiri T, Mori T, Kurokawa M,
Nawa Y, Uchida N, Morishita Y,
Leuk Res
Hashimoto H, Eto T, Hirokawa M,
Morishima Y, Nagamura-Inoue T, Atsuta
Y, Miyazaki Y.

2016

41:48-55.

WGP
8-3

Outcomes of Allogeneic Hematopoietic
Stem Cell Transplantation in Adult
92
Patients with Myelodysplastic Syndrome
Harboring Trisomy 8.

Konuma T, Miyazaki Y, Uchida N, Ohashi
K, Kondo T, Nakamae H, Takahashi S,
Mori T, Ozawa Y, Kato C, Iwato K, Fukuda Biol Blood
T, Ichinohe T, Atsuta Y, Ishiyama K; Adult Marrow
Myelodysplastic Syndrome Working Group Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

2017

23(1):7580.

WGP
8-4

2018

24(4):840
-8.

WGP
8-5

Kobayashi R, Fujita N, Mitsui T, Iwasaki F,
Stem cell transplantation for paediatricSuzumiya J, Kuroda H, Nishimura R,
Br J
94 patients with non-anaplastic peripheral T- Sasahara Y, Takeshita Y, Kato K,
Haematolcell lymphoma in Japan.
Okumura H, Sakamaki H, Yabe H, Kawa K,
Kato K, Suzuki R.

2012

159(1):88
-93.

WGP
9-1

Fukano R, Mori T, Kobayashi R, Mitsui T,
Fujita N, Iwasaki F, Suzumiya J, Chin M,
Br J
Goto H, Takahashi Y, Hara J, Park YD,
HaematolInoue M, Koga Y, Inagaki J, Sakamaki H,
Adachi S, Kawa K, Kato K, Suzuki R.

2015

168(4):55
7-63.

WGP
9-2

Kobayashi R, Mitsui T, Fujita N, Osumi T,
Outcome differences between children and Aoki T, Aoki K, Suzuki R, Fukuda T,
adolescents and young adults with nonMiyamoto T, Kato K, Nakamae H, Goto H,
96
Int J Hematol 2017
Hodgkin lymphoma following stem cell
Eto T, Inoue M, Mori T, Terui K, Onizuka
transplantation.
M, Koh K, Koga Y, Ichinohe T, Sawada A,
Atsuta Y, Suzumiya J.

105(3):36
9-76.

WGP
9-3

High-dose chemotherapy with autologous
stem cell transplantation for elderly
97 patients with relapsed/refractory diffuse
large B cell lymphoma: a nationwide
retrospective study.

2014

20(5):684
-9.

WGP
10-1

Kako S, Izutsu K, Kato K, Kim SW, Mori T,
Fukuda T, Kobayashi N, Taji H, Hashimoto
The role of hematopoietic stem cell
H, Kondo T, Sakamaki H, Morishima Y,
Am J
98 transplantation for relapsed and refractory Kato K, Suzuki R, Suzumiya J; Adult
Hematol
Hodgkin lymphoma.
Lymphoma Working Group of theJapanese Society for Hematopoietic Cell
Transplantation.

2015

90(2):132
-8.

WGP
10-2

Long-term survival following autologous
Aoki T, Suzuki R, Kuwatsuka Y, Kako S,
and allogeneic stem cell transplantation for Fujimoto K, Taguchi J, Kondo T, Ohata K,
99
Blood
blastic plasmacytoid dendritic cell
Ito T, Kamoda Y, Fukuda T, Ichinohe T,
neoplasm.
Takeuchi K, Izutsu K, Suzumiya J.

2015

125(23):3
559-62.

WGP
10-3

Yamasaki S, Suzuki R, Hatano K,
Fukushima K, Iida H, Morishima S, Suehiro
Y, Fukuda T, Uchida N, Uchiyama H, Ikeda
Bone Marrow
H, Yokota A, Tsukasaki K, Yamaguchi H,
2017
Transplant
Kuroda J, Nakamae H, Adachi Y,
Matsuoka KI, Nakamura Y, Atsuta Y,
Suzumiya J.

52(7):969
-76.

WGP
10-4

論文タイトル

Prognostic Impact of Donor Source on
Allogeneic Hematopoietic Stem Cell
Transplantation Outcomes in Adults with
93
Chronic Myelomonocytic Leukemia: A
Nationwide Retrospective Analysis inJapan.

Haematopoietic stem cell transplantation
for relapsed or refractory anaplastic large
95
cell lymphoma: a study of children andadolescents in Japan.

Therapy-related acute myeloid leukemia
and myelodysplastic syndrome after
100
hematopoietic cell transplantation for
lymphoma.

著者

Itonaga H, Aoki K, Aoki J, Ishikawa T,
Ishiyama K, Uchida N, Sakura T, Ohashi
K, Kurokawa M, Ozawa Y, Matsuoka KI,
Biol Blood
Nakamura Y, Kimura F, Iwato K, Nawa Y, Marrow
Hirokawa M, Kato K, Ichinohe T, Atsuta Y, TransplantMiyazaki Y.

Chihara D, Izutsu K, Kondo E, Sakai R,
Mizuta S, Yokoyama K, Kaneko H, Kato K, Biol Blood
Hasegawa Y, Chou T, Sugahara H,
Marrow
Henzan H, Sakamaki H, Suzuki R,
Transplant
Suzumiya J.

刊・号・
頁

業績
番号

Yamasaki S, Chihara D, Yoshida I, Kohda
Impact of hematopoietic stem cell
K, Sawa M, Ago H, Togitani K, Ohno Y,
101 transplantation in patients with relapsed or
Ann Hematol
Tanaka J, Fukuda T, Atsuta Y, Suzumiya
refractory marginal zone lymphoma.
J, Suzuki R

in press

WGP
10-5

Yamasaki S, Chihara D, Kim SW, Kawata
Risk factors and timing of autologous stem T, Mizuta S, Ago H, Chou T, Yamane T,
102 cell transplantation for patients with
Uchiyama H, Oyake T, Miura K, Saito B,
peripheral T-cell lymphoma.
Taji H, Nakamae H, Miyamoto T, Fukuda
T, Kanda J, Atsuta Y, Suzuki R

Int J Hematol 2019

109(2):17
5-86.

WGP
10-6

Yamasaki S, Chihara D, Kim SW, Izutsu K,
Impact of hematopoietic stem cellIwato K, Fukuda T, Uchida N, Amano I,
103 transplantation in patients with relapsed or Nakazawa H, Kuroda J, Hashimoto H,
Ann Hematol 2018refractory mantle cell lymphoma.
Ichinohe T, Kanda Y, Atsuta Y, SuzumiyaJ, Suzuki R

97(8):144
5-52.

WGP
10-7

Long-term outcome of childhood aplastic
anemia patients who underwent allogeneic
104
hematopoietic SCT from an HLA-matchedsibling donor in Japan.

Kikuchi A, Yabe H, Kato K, Koh K, Inagaki
J, Sasahara Y, Suzuki R, Yoshida N, Kudo Bone Marrow
2013
K, Kobayashi R, Tabuchi K, Kawa K,
Transplant
Kojima S.

48(5):657
-60.

WGP
11-1

Yoshida N, Kobayashi R, Yabe H, Kosaka
First-line treatment for severe aplastic
Y, Yagasaki H, Watanabe K, Kudo K,
anemia in children: bone marrow
Haematologic
105
Morimoto A, Ohga S, Muramatsu H,
2014
transplantation from a matched familyaTakahashi Y, Kato K, Suzuki R, Ohara A,
donor versus immunosuppressive therapy.
Kojima S.

99(12):17
84-91.

WGP
11-2

2014

20(8):114
5-9.

WGP
11-3

Kudo K, Muramatsu H, Yoshida N,
Second allogeneic hematopoietic stem cell Kobayashi R, Yabe H, Tabuchi K, Kato K,
Bone Marrow
107 transplantation in children with severe
Koh K, Takahashi Y, Hashii Y, Kawano Y,
2015
Transplant
aplastic anemia.
Inoue M, Cho Y, Sakamaki H, Kawa K,
Kato K, Suzuki R, Kojima S.

50(10):13
12-5.

WGP
11-4

52(12):16
59-61.

WGP
11-5

103(4):46
1-8.

WGP
12-1

2017

23(12):21
37-42.

WGP
12-2

2012

120(8):17
34-41.

WGP
13-1

論文タイトル

Bloodstream infection after stem cell
106 transplantation in children with idiopathic
aplastic anemia.

Unrelated cord blood transplantation in
108 aplastic anemia: is antithymocyte globulin
indispensable for conditioning?

著者

雑誌名

Kobayashi R, Yabe H, Kikuchi A, Kudo K,
Yoshida N, Watanabe K, Muramatsu H,
Biol Blood
Takahashi Y, Inoue M, Koh K, Inagaki J,
Marrow
Okamoto Y, Sakamaki H, Kawa K, Kato K, Transplant
Suzuki R, Kojima S.

発行
年

Kudo K, Muramatsu H, Narita A, Yoshida
N, Kobayashi R, Yabe H, Endo M, Inoue M,
Bone Marrow
Hara J, Kounami S, Inagaki J, Hashii Y,
2017Transplant
Kato K, Tabuchi K, Kojima S.

Impact of cyclophosphamide dose ofMori T, Koh H, Onishi Y, Kako S, Onizuka
conditioning on the outcome of allogeneic
M, Kanamori H, Ozawa Y, Kato C, Iida H,
109 hematopoietic stem cell transplantation for
Int J Hematol 2016
Suzuki R, Ichinohe T, Kanda Y, Maeda T,
aplastic anemia from human leukocyte
Nakao S, Yamazaki H.
antigen-identical sibling.
Onishi Y, Mori T, Kako S, Koh H, Uchida
N, Kondo T, Kobayashi T, Yabe H,
Outcome of Second Transplantation Using Miyamoto T, Kato K, Suzuki R, Nakao S,
Umbilical Cord Blood for Graft Failure after Yamazaki H; Adult Aplastic Anemia
110
Allogeneic Hematopoietic Stem Cell
Working Group of the Japan Society forTransplantation for Aplastic Anemia.
Hematopoietic Cell Transplantation.

Allogeneic hematopoietic stem celltransplantation for adult T-cell leukemia111 lymphoma with special emphasis on
preconditioning regimen: a nationwide
retrospective study.

Biol Blood
Marrow
Transplant

Ishida T, Hishizawa M, Kato K, Tanosaki
R, Fukuda T, Taniguchi S, Eto T,
Takatsuka Y, Miyazaki Y, Moriuchi Y,
Blood
Hidaka M, Akashi K, Uike N, Sakamaki H,
Morishima Y, Kato K, Suzuki R, Nishiyama
T, Utsunomiya A.

論文タイトル

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

Impact of graft-versus-host disease on
allogeneic hematopoietic cell
112 transplantation for adult T cell leukemialymphoma focusing on preconditioning
regimens: nationwide retrospective study.

Ishida T, Hishizawa M, Kato K, Tanosaki
R, Fukuda T, Takatsuka Y, Eto T,
Miyazaki Y, Hidaka M, Uike N, Miyamoto
T, Tsudo M, Sakamaki H, Morishima Y,
Suzuki R, Utsunomiya A.

Biol Blood
Marrow
Transplant2013

19(12):17
31-9.

WGP
13-2

Treatment of patients with adult T cellleukemia/lymphoma with cord blood
113
transplantation: a Japanese nationwide
retrospective survey.

Kato K, Choi I, Wake A, Uike N, Taniguchi
S, Moriuchi Y, Miyazaki Y, Nakamae H,
Biol Blood
Oku E, Murata M, Eto T, Akashi K,
Marrow
Sakamaki H, Kato K, Suzuki R, Yamanaka Transplant
T, Utsunomiya A.

2014

20(12):19
68-74.

WGP
13-3

Early application of related SCT might
114 improve clinical outcome in adult T-cellleukemia/lymphoma.

Fuji S, Fujiwara H, Nakano N, Wake A,
Inoue Y, Fukuda T, Hidaka M, Moriuchi Y,
Miyamoto T, Uike N, Taguchi J, Eto T,
Bone Marrow
Tomoyose T, Kondo T, Yamanoha A,
2016
Transplant
Ichinohe T, Atsuta Y, Utsunomiya A; ATL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

51(2):205
-11.

WGP
13-4

Fujiwara H, Fuji S, Wake A, Kato K,
Takatsuka Y, Fukuda T, Taguchi J, Uchida
Dismal outcome of allogeneic
N, Miyamoto T, Hidaka M, Miyazaki Y,
hematopoietic stem cell transplantation forBone Marrow
115
Tomoyose T, Onizuka M, Takanashi M,
2017relapsed adult T-cell leukemia/lymphoma,
Transplant
Ichinohe T, Atsuta Y, Utsunomiya A; ATLa Japanese nation-wide study.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

52(3):484
-8.

WGP
13-5

24(4):832
-9.

WGP
13-6

37(1):5461.

WGP
13-7

in press

WGP
13-8

106(2):17
9-85.

WGP
14-1

Risk Assessment in Adult T Cell
Leukemia/Lymphoma Treated with
116 Allogeneic Hematopoietic Stem Cell
Transplantation.

The outcome and characteristics ofpatients with relapsed adult T cell117
leukemia/lymphoma after allogeneic
hematopoietic stem cell transplantation.

Yoshimitsu M, Tanosaki R, Kato K, Ishida
T, Choi I, Takatsuka Y, Fukuda T, Eto T,
Hidaka M, Uchida N, Miyamoto T,
Nakashima Y, Moriuchi Y, Nagafuji K,
Biol Blood
Miyazaki Y, Ichinohe T, Takanashi M,
Marrow
Atsuta Y, Utsunomiya A; ATL Working
TransplantGroup of the Japan Society for
Hematopoietic Cell Transplantation.

2018

Kato K, Uike N, Wake A, Yoshimitsu M,
Tobai T, Sawayama Y, Takatsuka Y,
Fukuda T, Uchida N, Eto T, Nakashima Y,
Kondo T, Taguchi J, Miyamoto T,
HematologicalNakamae H, Ichinohe T, Kato K, Suzuki R,
2019
Oncology
Utsunomiya A; ATL Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

Yoshimitsu M, Utsunomiya A, Fuji S,
A retrospective analysis of haplo-identical Fujiwara H, Fukuda T, Ogawa H,
HLA-mismatch hematopoietic
Takatsuka Y, Ishitsuka K, Yokota A,
transplantation without posttransplantation Okumura H, Ishii K, Nishikawa A, Eto T,
Bone Marrow118
cyclophosphamide for GVHD prophylaxis in Yonezawa A, Miyashita K, Tsukada J,
Transplantpatients with adult T-cell leukemiaTanaka J, Atsuta Y, Kato K; ATL Working
lymphoma.
Group of the Japan Society for
Hematopoietic Cell Transplantation.
Changing trends in prognostic factors for
Takamatsu H, Honda S, Miyamoto T,
patients with multiple myeloma after
Yokoyama K, Hagiwara S, Ito T, Tomita N,
119 autologous stem cell transplantation during
Cancer Sci
Iida S, Iwasaki T, Sakamaki H, Suzuki R,
the immunomodulator drug/proteasome
Sunami K.
inhibitor era.

2015

雑誌名

発行
年

刊・号・
頁

業績
番号

Cord Blood Transplantation for Multiple
Myeloma:A Study from the Multiple
120 Myeloma Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Kawamura K, Takamatsu H, Ikeda T,
Komatsu T, Aotsuka N, Amano I,
Biol Blood
Yamamoto G, Watanabe K, Ohno Y,
Marrow
Matsue K, Kouzai Y, Tsukada N, Ishiyama
Transplant
K, Anzai N, Kato K, Suzuki R, Sunami K,
Kanda Y.

2015

21(7):129
1-8.

WGP
14-2

Tandem autologous versus
autologous/allogeneic transplantation for121
multiple myeloma: propensity scoreanalysis.

Kawamura K, Ikeda T, Hagiwara S, Mori T,
Shinagawa A, Nishiwaki K, Ohashi K,
Leuk
Kubonishi S, Fukuda T, Ito T, Tomita N,
LymphomaIchinohe T, Kato K, Morishima Y, Atsuta
Y, Sunami K, Kanda Y.

2016

57(9):207
7-83.

WGP
14-3

Significance of Salvage Autologous Stem
Cell Transplantation for Relapsed Multiple
122
Myeloma: A Nationwide Retrospective
Study in Japan.

Muta T, Miyamoto T, Kamimura T, Kanda
Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Acta
Mori T, Uchida N, Iida S, Fukuda T,
Haematol
Atsuta Y, Sunami K.

2018

139(1):35
-44.

WGP
14-4

Takamatsu H, Yamashita T, Kurahashi S,
Clinical Implications of t(11;14) in Patients Saitoh T, Kondo T, Maeda T, Nakazawa H, Biol Blood
123 with Multiple Myeloma Undergoing
Murata M, Narita T, Kuroda J, Hashimoto Marrow
Autologous Stem Cell Transplantation.
H, Kawamura K, Miyamoto T, Honda S,
Transplant
Ichinohe T, Atsuta Y, Sunami K.

in press

WGP
14-5

Efficacy of high-dose chemotherapy with
124 stem cell transplantation
for hepatoblastoma in Japan.

54(2):126
-32.

WGP
15-1

63(12):22
21-9.

WGP
16-1

40(2):137
-40.

WGP
16-2

in press

WGP
16-3

161(4):56
6-77.

WGP
17-1

3:e164.

WGP
17-2

98(5):814
-22.

WGP
17-3

論文タイトル著者

山本将平，渡邊健一郎，井上雅美，橋井 日本小児血佳子，菊田 敦，金子 隆，加藤剛二，原 液・がん学会 2017
純一，田渕 健，高橋義行
雑誌

Umeda K, Adachi S, Tanaka S, Miki M,
Comparison of second transplantation and Okada K, Hashii Y, Inoue M, Cho Y, Kohdonor lymphocyte infusion for donor mixed K, Goto H, Kajiwara R, Hyakuna N, Kato
125
chimerism after allogeneic stem cell
K, Morio T, Yabe H; Inherited Diseasetransplantation for nonmalignant diseases. Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

126

Allogeneic Hematopoietic Stem Cell
Transplantation for Leukocyte Adhesion
Deficiency.

Pediatr Blood
2016
CancerHorikoshi Y, Umeda K, Imai K, Yabe H,
J Pediatr
Sasahara Y, Watanabe K, Ozawa Y, Hashii
HematolY, Kurosawa H, Nonoyama S, Morio T.
Oncol

Umeda K, Yabe H, Kato K, Imai K,
Impact of low-dose irradiation and in vivo Kobayashi M, Takahashi Y, Yoshida N,
T-cell depletion on hematopoietic stem
Sato M, Sasahara Y, Kato K, Adachi S,
127 cell transplantation for non-malignant
Koga Y, Okada K, Inoue M, Hashii Y,
diseases using fludarabine-based reduced- Atsuta Y, Morio T; Inherited Diseaseintensity conditioning.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

Bone Marrow
Transplant

Impact of a single human leucocyte antigen(HLA) allele mismatch on the outcome of
Kanda Y, Kanda J, Atsuta Y, Maeda Y,
unrelated bone marrow transplantation
Ichinohe T, Ohashi K, Fukuda T, Miyamura Br J
128 over two time periods. A retrospective
K, Iida H, Mori T, Iwato K, Eto T, Kawa K, Haematol
analysis of 3003 patients from the HLA
Morita S, Morishima Y.
Working Group of the Japan Society for
Blood and Marrow Transplantation.
Effects of KIR ligand incompatibility on
clinical outcomes of umbilical cord blood
129
transplantation without ATG for acuteleukemia in complete remission.

2018

2013

Tanaka J, Morishima Y, Takahashi Y,
Yabe T, Oba K, Takahashi S, Taniguchi S,
Blood Cancer
Ogawa H, Onishi Y, Miyamura K, Kanamori
2013
J
H, Aotsuka N, Kato K, Kato S, Atsuta Y,
Kanda Y.

Atsuta Y, Kanda J, Takanashi M,
Morishima Y, Taniguchi S, Takahashi S,
Different effects of HLA disparity on
Ogawa H, Ohashi K, Ohno Y, Onishi Y,
transplant outcomes after single-unit cord
130
Aotsuka N, Nagamura-Inoue T, Kato K,
blood transplantation between pediatricKanda Y; HLA Working Group of theand adult patients with leukemia.
Japan Society for Hematopoietic Cell
Transplantation.

Haematologic
2013
a

雑誌名

発行
年

刊・号・
頁

業績
番号

Kanda J, Atsuta Y, Wake A, Ichinohe T,
Takanashi M, Morishima Y, Taniguchi S,
Takahashi S, Ogawa H, Ohashi K, Ohno Y, Biol Blood
Aotsuka N, Onishi Y, Kato K, Nagamura- Marrow
Inoue T, Kanda Y; HLA Working Group of Transplant
the Japan Society for Hematopoietic Cell
Transplantation.

2013

19(2):247
-54.

WGP
17-4

Kanda Y, Kanda J, Atsuta Y, Fuji S,
Maeda Y, Ichinohe T, Takanashi M,
Changes in the clinical impact of high-risk
Ohashi K, Fukuda T, Miyamura K, Mori T, Biol Blood
human leukocyte antigen allele mismatch132
Sao H, Kobayashi N, Iwato K, Sawada A, Marrowcombinations on the outcome of unrelatedMori S; HLA working group of the Japan Transplantbone marrow transplantation.
Society for Hematopoietic Cell
Transplantation.

2014

20(4):526
-35.

WGP
17-5

4:e263.

WGP
17-6

Impact of HLA allele mismatch on the
134 clinical outcome in serologically matched
related hematopoietic SCT.

Fuji S, Kanda J, Kato S, Ikegame K,
Morishima S, Miyamoto T, Hidaka M, Kubo
K, Miyamura K, Ohashi K, Kobayashi H,
Bone Marrow
Maesako Y, Adachi S, Ichinohe T, Atsuta
2014
Transplant
Y, Kanda Y; HLA Working Group of Japan
Society for Hematopoietic Cell
Transplantation.

49(9):118
7-92.

WGP
17-7

Impact of HLA mismatch direction on theoutcome of unrelated bone marrow
135 transplantation: a retrospective analysis
from the Japan Society for Hematopoietic
Cell Transplantation.

Kanda J, Ichinohe T, Fuji S, Maeda Y,
Ohashi K, Fukuda T, Miyamura K, Iwato K,
Biol Blood
Eto T, Nakamae H, Kobayashi N, Mori T,
MarrowMori S, Morishima Y, Atsuta Y, Kanda Y;
Transplant
HLA Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

201521(2):305
-11.

WGP
17-8

Fuji S, Kanda J, Kato S, Ikegame K,
A single high-resolution HLA mismatch has Morishima S, Miyamoto T, Hidaka M, Kubo
a similar adverse impact on the outcome K, Miyamura K, Tsudo M, Kobayashi H,
Am J
136 of related hematopoietic stem cell
Maesako Y, Eto T, Adachi S, Ichinohe T,
Hematoltransplantation as a single low-resolution Atsuta Y, Kanda Y; HLA Working Group of
HLA mismatch.
the Japan Society for Hematopoietic Cell
Transplantation.

2015

90(7):618
-23.

WGP
17-9

Yanada M, Kanda J, Ohtake S, Fukuda T,
Sakamaki H, Miyamura K, Miyawaki S,
Uchida N, Maeda T, Nagamura-Inoue T, Eur J
Asou N, Morishima Y, Atsuta Y, Miyazaki HaematolY, Kimura F, Kobayashi Y, Takami A, Naoe
T, Kanda Y.

2016

97(3):278 WGP
-87.
17-10

Arima N, Nakamura F, Yabe T, Tanaka J,
Influence of Differently Licensed KIR2DL1Fuji S, Ohashi K, Fukuda T, Miyamura K, Biol Blood
Positive Natural Killer Cells in Transplant138
Iwato K, Eto T, Mori T, Kobayashi N,
Marrow
Recipients with Acute Leukemia: A
Hoshino T, Kato C, Kanamori H, Nakamae Transplant
Japanese National Registry Study.
H, Atsuta Y, Morishima Y, Kanda Y.

201622(3):423 WGP
-31.
17-11

Kanda J, Ikegame K, Fuji S, Kurokawa M,
Kanamori H, Fukuda T, Ohashi K, Ishikawa
Biol BloodJ, Ogawa H, Inoue M, Ichinohe T, Atsuta
Marrow
Y, Kanda Y; HLA Working Group of theTransplant
Japan Society for Hematopoietic Cell
Transplantation.

2016

22(11):20 WGP
31-7.
17-12

論文タイトルImpact of the direction of HLA mismatch
131 on transplantation outcomes in single
unrelated cord blood transplantation.

著者

Kanda J, Fuji S, Kato S, Takami A,
Tanaka J, Miyamura K, Ohashi K, Fukuda
T, Ozawa Y, Kanamori H, Eto T,
Decision analysis for donor selection in
Kobayashi N, Iwato K, Morishima Y,
stem cell transplantation-HLA-8/8 alleleBlood Cancer
133
Sakamaki H, Atsuta Y, Kanda Y; HLA
2014
matched unrelated donor vs HLA-1 AG
J
Working Group; Donor/Source Working
mismatched related donor.
Group; Adult AML Working Group; Adult
ALL Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

Unrelated bone marrow transplantation or
immediate umbilical cord blood
137 transplantation for patients with acute
myeloid leukemia in first complete
remission.

Haploidentical and Matched Sibling Donor
Hematopoietic Cell Transplantation for
139
Patients with HLA-Homozygous
Haplotypes.

論文タイトル

著者

雑誌名

Yokoyama H, Kanda J, Fuji S, Kim SW,
Fukuda T, Najima Y, Ohno H, Uchida N,
Impact of Human Leukocyte Antigen Allele Ueda Y, Eto T, Iwato K, Kobayashi H,
Biol Blood
Mismatch in Unrelated Bone Marrow
Ozawa Y, Kondo T, Ichinohe T, Atsuta Y,
140
Marrow
Transplantation with Reduced-Intensity
Kanda Y; HLA Working Group of theTransplant
Conditioning Regimen.
Japan Society for Hematopoietic Cell
Transplantation.

Impact of the presence of HLA 1-locus
mismatch and the use of low-dose141
antithymocyte globulin in unrelated bonemarrow transplantation.

発行
年

刊・号・
頁

2017

23(2):300 WGP
-9.
17-13

Kawamura K, Kanda J, Fuji S, Murata M,
Ikegame K, Yoshioka K, Fukuda T, Ozawa
Y, Uchida N, Iwato K, Sakura T, Hidaka M, Bone Marrow
2017
Hashimoto H, Ichinohe T, Atsuta Y, Kanda Transplant
Y.

業績
番号

52(10):13 WGP
90-8.
17-14

Homozygous HLA-C1 is Associated with
Reduced Risk of Relapse after HLA142
Matched Transplantation in Patients with
Myeloid Leukemia.

Arima N, Kanda J, Tanaka J, Yabe T,
Morishima Y, Kim SW, Najima Y, Ozawa Y, Biol Blood
Eto T, Kanamori H, Mori T, Kobayashi N, Marrow
Kondo T, Nakamae H, Uchida N, Inoue M, Transplant
Fukuda T, Ichinohe T, Atsuta Y, Kanda Y.

Comparison of HLA Allele Mismatch andAntigen Mismatch in Unrelated Bone
143
Marrow Transplantation in Patients with
Leukemia.

Atsuta Y , Kato S , Morishima Y , Ohashi
K , Fukuda T , Ozawa Y , Eto T , Iwato K ,Biol Blood
Uchida N , Ota S , Onizuka M , Ichinohe T
Marrow, Kanda J , Kanda Y ; HLA Working Group
Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

in press

WGP
17-16

HLA discrepancy between graft and host
144 rather than that graft and first donor
impact the second transplant outcome.

Maeda Y , Ugai T , Kondo E , Ikegame K ,Murata M , Uchida N , Miyamoto T ,Takahashi S , Ohashi K , Nakamae H ,Haematologic
Fukuda T , Onizuka M , Eto T , Ota S ,aHirokawa M , Ichinohe T , Atsuta Y ,Kanda Y , Kanda J

in press

WGP
17-17

2018

24(4):717 WGP
-25.
17-15

Kanda J, Ichinohe T, Kato S, Uchida N,
Terakura S, Fukuda T, Hidaka M, Ueda Y,
Unrelated cord blood transplantation vsKondo T, Taniguchi S, Takahashi S,
related transplantation with HLA 1-antigen Nagamura-Inoue T, Tanaka J, Atsuta Y,
145
Leukemia
mismatch in the graft-versus-host
Miyamura K, Kanda Y; Donor/Source
direction.
Working Group and HLA Working Group of
the Japan Society for Hematopoietic Cell
Transplantation.

2013

27(2):286
-94.

WGP
18-1

Graft-versus-host disease and survival
after cord blood transplantation for acute146
leukemia: a comparison of Japaneseversus White populations.

Kuwatsuka Y, Atsuta Y, Horowitz MM,
Inagaki J, Kanda J, Kato K, Koh K, Zhang
MJ, Eapen M; Center for International
Biol Blood
Blood and Marrow Transplant Research
Marrow(CIBMTR), and Donor/Source and GVHD
Transplant
Working Group of the Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

2014

20(5):662
-7.

WGP
18-2

Comparison of cord blood transplantation
with unrelated bone marrow
147
transplantation in patients older than fifty
years.

Tanaka M, Miyamura K, Terakura S, Imai
Biol Blood
K, Uchida N, Ago H, Sakura T, Eto T,
Marrow
Ohashi K, Fukuda T, Taniguchi S, Mori S,
Transplant
Nagamura-Inoue T, Atsuta Y, Okamoto S.

201521(3):517
-25.

WGP
18-3

2016

22(2):330
-8.

WGP
18-4

Terakura S, Atsuta Y, Tsukada N,
Comparison of Outcomes of 8/8 and 7/8
Kobayashi T, Tanaka M, Kanda J, Najima
Allele-Matched Unrelated Bone Marrow
Y, Fukuda T, Uchida N, Takahashi S,
148 Transplantation and Single-Unit Cord
Nagamura-Inoue T, Morishima Y,
Blood Transplantation in Adults with Acute
Miyamura K; Japan Society for
Leukemia.
Hematopoietic Cell Transplantation.

Biol Blood
Marrow
Transplant

雑誌名

発行
年

刊・号・
頁

業績
番号

Kumar R, Kimura F, Ahn KW, Hu ZH,
Kuwatsuka Y, Klein JP, Pasquini M,
Comparing Outcomes with Bone Marrow or Miyamura K, Kato K, Yoshimi A, Inamoto
Peripheral Blood Stem Cells as Graft
Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel Biol Blood
149 Source for Matched Sibling Transplants in M, Rowlings P, Marks DI, Schultz KR,
Marrow
Severe Aplastic Anemia across Different Gupta V, Dedeken L, George B, Cahn JY, Transplant
Economic Regions.
Szer J, Lee JW, Ho AY, Fasth A, Hahn T,
Khera N, Dalal J, Bonfim C, Aljurf M,
Atsuta Y, Saber W.

201622(5):932
-40.

WGP
18-5

Graft-versus-Host Disease after HLAMatched Sibling Bone Marrow orPeripheral Blood Stem Cell
150
Transplantation: Comparison of North
American Caucasian and Japanese
Populations.

Kanda J, Brazauskas R, Hu ZH,
Kuwatsuka Y, Nagafuji K, Kanamori H,
Kanda Y, Miyamura K, Murata M, Fukuda Biol Blood
T, Sakamaki H, Kimura F, Seo S, Aljurf M, Marrow
Yoshimi A, Milone G, Wood WA, Ustun C, Transplant
Hashimi S, Pasquini M, Bonfim C, Dalal J,
Hahn T, Atsuta Y, Saber W.

201622(4):744
-51.

WGP
18-6

Comparison of Donor Sources in
Hematopoietic Stem Cell Transplantation
151
for Childhood Acute Leukemia: A
Nationwide Retrospective Study.

Sakaguchi H, Watanabe N, Matsumoto K,
Yabe H, Kato S, Ogawa A, Inagaki J, Goto
H, Koh K, Yoshida N, Kato K, Cho Y,
Biol Blood
Kosaka Y, Takahashi Y, Inoue M, Kato K, Marrow
Atsuta Y, Miyamura K; Donor/Source
Transplant
Working Group of Japan Society of
Hematopoietic Cell Transplantation.

2016

22(12):22
26-34.

WGP
18-7

Kuwatsuka Y, Kanda J, Yamazaki H, Mori
T, Miyamura K, Kako S, Uchida N, Ohashi
A Comparison of Outcomes for Cord Blood K, Ozawa Y, Takahashi Y, Kato C, Iwato
Biol Blood
Transplantation and Unrelated BoneK, Ishiyama K, Kobayashi H, Eto T, Kahata
152
Marrow
Marrow Transplantation in Adult Aplastic K, Kato J, Miyamoto T, Kato K, Mori S,
Transplant
Anemia.
Atsuta Y, Kimura F, Kanda Y; Japan
Society for Hematopoietic Cell
Transplantation.

2016

22(10):18
36-43.

WGP
18-8

Konuma T, Tsukada N, Kanda J, UchidaN, Ohno Y, Miyakoshi S, Kanamori H,
Comparison of transplant outcomes from Hidaka M, Sakura T, Onizuka M,
matched sibling bone marrow or peripheral Kobayashi N, Sawa M, Eto T, Matsuhashi Am J
153
blood stem cell and unrelated cord blood in Y, Kato K, Ichinohe T, Atsuta Y, Miyamura Hematol
patients 50 years or older.
K; Donor/Source Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

2016

91(5):E28 WGP
4-92.
18-9

Clinical factors predicting the response of
acute graft-versus-host disease tocorticosteroid therapy: an analysis from154
the GVHD Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Murata M, Nakasone H, Kanda J, Nakane
T, Furukawa T, Fukuda T, Mori T,
Biol Blood
Taniguchi S, Eto T, Ohashi K, Hino M,
Marrow
Inoue M, Ogawa H, Atsuta Y, NagamuraTransplant
Inoue T, Yabe H, Morishima Y, Sakamaki
H, Suzuki R.

2013

19(8):118
3-9.

WGP
19-1

A case-control study of bronchiolitis
155 obliterans syndrome following allogeneic
hematopoietic stem cell transplantation.

Nakasone H, Kanda J, Yano S, Atsuta Y,
Ago H, Fukuda T, Kakihana K, Adachi T,
Yujiri T, Taniguchi S, Taguchi J,
Morishima Y, Nagamura T, Sakamaki H,
Mori T, Murata M; GVHD Working Groupof the Japan Society for Hematopoietic
Cell Transplantation.

2013

26(6):631
-9.

WGP
19-2

Kanda J, Nakasone H, Atsuta Y, Toubai T,
Yokoyama H, Fukuda T, Taniguchi S,
Bone Marrow
Ohashi K, Ogawa H, Eto T, Miyamura K,
2014
Transplant
Morishima Y, Nagamura-Inoue T,
Sakamaki H, Murata M.

49(2):228
-35.

WGP
19-3

論文タイトル

156

Risk factors and organ involvement ofchronic GVHD in Japan.

著者

Transpl Int

発行
年

刊・号・
頁

業績
番号

Nakasone H, Fukuda T, Kanda J, Mori T,
Yano S, Kobayashi T, Miyamura K, Eto T,
Impact of conditioning intensity and TBI on Kanamori H, Iwato K, Uchida N, Mori S,
Bone Marrow
157 acute GVHD after hematopoietic cell
Nagamura-Inoue T, Ichinohe T, Atsuta Y,
2015
Transplanttransplantation.
Teshima T, Murata M; GVHD working
group of the Japan Society of
Hematopoietic Cell Transplantation.

50(4):559
-65.

WGP
19-4

Age influences post-graft-versus-hostdisease non-relapse mortality in adults
158 with acute graft-versus-host disease ofvarying severity following allogeneic
hematopoietic cell transplant.

2015

56(8):239
2-7.

WGP
19-5

Umeda K, Adachi S, Tanaka S, Ogawa A,
Hatakeyama N, Kudo K, Sakata N,
Comparison of continuous and twice-daily Igarashi S, Ohshima K, Hyakuna N, Chin
infusions of cyclosporine A for graftM, Goto H, Takahashi Y, Azuma E, Koh K,
Pediatr Blood
159 versus-host-disease prophylaxis in
Sawada A, Kato K, Inoue M, Atsuta Y,
2015
Cancerpediatric hematopoietic stem cell
Takami A, Murata M; on behalf of thetransplantation.
GVHD Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

62(2):291
-8.

WGP
19-6

Sakai R, Taguri M, Oshima K, Mori T, Ago
H, Adachi S, Morita S, Taniguchi S,
Fukuda T, Ohashi K, Eto T, Miyamura K,
Int J Hematol 2016
Iwato K, Kobayashi N, Kanamori H,
Morishima Y, Nagamura-Inoue T,
Sakamaki H, Atsuta Y, Murata M.

103(3):32
2-33.

WGP
19-7

51(1):96102.

WGP
19-8

31(3):663
-8.

WGP
19-9

論文タイトル

A comparison of tacrolimus andcyclosporine combined with methotrexate
160 for graft-versus-host disease prophylaxis,
stratified by stem cell source: aretrospective nationwide survey.

著者

雑誌名

Nakane T, Fukuda T, Kanda J, Taniguchi
S, Eto T, Ohashi K, Nakamae H, Kurokawa Leuk
M, Mori T, Morishima Y, Nagamura-Inoue Lymphoma
T, Sakamaki H, Atsuta Y, Murata M.

Arai Y, Kanda J, Nakasone H, Kondo T,
Risk factors and prognosis of hepatic
Uchida N, Fukuda T, Ohashi K, Kaida K,
161 acute GvHD after allogeneic hematopoietic Iwato K, Eto T, Kanda Y, Nakamae H,cell transplantation.
Nagamura-Inoue T, Morishima Y,
Hirokawa M, Atsuta Y, Murata M.

Bone Marrow
2016
Transplant

Impact of graft-versus-host disease on
162 outcomes after unrelated cord bloodtransplantation.

Kanda J, Morishima Y, Terakura S, Wake
A, Uchida N, Takahashi S, Ono Y, Onishi
Y, Kanamori H, Aotsuka N, Ozawa Y,
Leukemia
Ogawa H, Sakura T, Ohashi K, Ichinohe T,
Kato K, Atsuta Y, Teshima T, Murata M.

Low-dose thymoglobulin as second-line
163 treatment for steroid-resistant acute
GvHD: an analysis of the JSHCT.

Murata M, Ikegame K, Morishita Y, Ogawa
H, Kaida K, Nakamae H, Ikeda T, Nishida
T, Inoue M, Eto T, Kubo K, Sakura T, Mori Bone Marrow
2017
T, Uchida N, Ashida T, Matsuhashi Y,
TransplantMiyazaki Y, Ichinohe T, Atsuta Y, TeshimaT.

52(2):252 WGP
-7.
19-10

Exploratory research for optimal GvHD
prophylaxis after single unit CBT in adults:
164 short-term methotrexate reduced theincidence of severe GvHD more than
mycophenolate mofetil.

Terakura S, Wake A, Inamoto Y, Murata
M, Sakai R, Yamaguchi T, Takahashi S,
Uchida N, Onishi Y, Ohashi K, Ozawa Y,
Kanamori H, Yamaguchi H, Fukuda T,
Ichinohe T, Takanashi M, Atsuta Y,
Teshima T.

Bone Marrow
2017
Transplant52(3):423 WGP
-30.
19-11

Inamoto Y, Kimura F, Kanda J, Sugita J,
Comparison of graft-versus-host diseaseIkegame K, Nakasone H, Nannya Y,
free, relapse-free survival according to a
Uchida N, Fukuda T, Yoshioka K, Ozawa Haematologic
165 variety of graft sources: antithymocyte
2016
Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, a
globulin and single cord blood provide
Inoue M, Teshima T; JSHCT GVHD
favorable outcomes in some subgroups.
Working Group.

101(12):1 WGP
592-602. 19-12

Arai Y, Kondo T, Yamazaki H, Takenaka K,
Sugita J, Kobayashi T, Ozawa Y, UchidaN, Iwato K, Kobayashi N, Takahashi Y,
Haematologic
2016
Ishiyama K, Fukuda T, Ichinohe T, Atsuta a
Y, Mori T, Teshima T; Japan Society for
Hematopoietic Cell Transplantation.

101(5):64 WGP
4-52.
19-13

Allogeneic unrelated bone marrowtransplantation from older donors results
166
in worse prognosis in recipients withaplastic anemia.

2017論文タイトル

著者

雑誌名

発行
年

Terakura S, Kuwatsuka Y, Yamasaki S,
Wake A, Kanda J, Inamoto Y, Mizuta S,
GvHD prophylaxis after single-unit reduced Yamaguchi T, Uchida N, Kouzai Y,
intensity conditioning cord blood
Aotsuka N, Ogawa H, Kanamori H,
Bone Marrow
167
2017transplantation in adults with acuteNishiwaki K, Miyakoshi S, Onizuka M,
Transplantleukemia.
Amano I, Fukuda T, Ichinohe T, Atsuta Y,
Murata M, Teshima T.

刊・号・
頁

業績
番号

52(9):126 WGP
1-7.
19-14

Impacts of thymoglobulin in patients with
168 acute leukemia in remission undergoing
allogeneic HSCT from different donors.

Wakamatsu M, Terakura S, Ohashi K,
Fukuda T, Ozawa Y, Kanamori H, Sawa M,
Uchida N, Ota S, Matsushita A, Kanda Y,
Blood
Nakamae H, Ichinohe T, Kato K, Murata
Advances
M, Atsuta Y, Teshima T; GVHD Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

2019

3(2):105- WGP
15.
19-15

Impact of hepatitis C virus infection onclinical outcome in recipients after169
allogeneic hematopoietic celltransplantation.

Nakasone H, Kurosawa S, Yakushijin K,
Taniguchi S, Murata M, Ikegame K,
Kobayashi T, Eto T, Miyamura K,
Sakamaki H, Morishima Y, Nagamura T,
Suzuki R, Fukuda T.

2013

88(6):477
-84.

WGP
20-1

170

Pre-transplant risk factors for cryptogenic Nakasone H, Onizuka M, Suzuki N, Fujii N,
organizing pneumonia/bronchiolitis
Taniguchi S, Kakihana K, Ogawa H,
Bone Marrow2013
obliterans organizing pneumonia after
Miyamura K, Eto T, Sakamaki H, Yabe H, Transplant
hematopoietic cell transplantation.
Morishima Y, Kato K, Suzuki R, Fukuda T.

48(10):13
17-23.

WGP
20-2

171

Salvage allogeneic hematopoietic SCT for
primary graft failure in children.

Kato M, Matsumoto K, Suzuki R, Yabe H,
Inoue M, Kigasawa H, Inagaki J, Koh K,
Bone Marrow2013
Hashii Y, Tauchi H, Suminoe A, Kikuta A, Transplant
Sakamaki H, Kawa K, Kato K, Fukuda T.

48(9):117
3-8.

WGP
20-3

Impact of pretransplant body mass index
172 on the clinical outcome after allogeneic
hematopoietic SCT.

Fuji S, Takano K, Mori T, Eto T, Taniguchi
Bone Marrow
S, Ohashi K, Sakamaki H, Morishima Y,
2014
Transplant
Kato K, Miyamura K, Suzuki R, Fukuda T.

49(12):15
05-12.

WGP
20-4

Cytomegalovirus Reactivation after
Allogeneic Hematopoietic Stem Cell
Transplantation is Associated with a
Reduced Risk of Relapse in Patients with
173 Acute Myeloid Leukemia Who Survived to
Day 100 after Transplantation: The Japan
Society for Hematopoietic Cell
Transplantation Transplantation-related
Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y,
Oshima K, Ohashi K, Mori T, Kanamori H, Biol Blood
Miyamura K, Kato C, Kobayashi N, Uchida Marrow
N, Nakamae H, Ichinohe T, Morishima Y, Transplant
Suzuki R, Yamaguchi T, Fukuda T.

2015

21(11):20
08-16.

WGP
20-5

Bone Marrow
2015
Transplant50(4):553
-8.

WGP
20-6

Yakushijin K, Atsuta Y, Doki N, Yokota A,
Kanamori H, Miyamoto T, Ohwada C,
Miyamura K, Nawa Y, Kurokawa M,
Bone Marrow
2016
Mizuno I, Mori T, Onizuka M, Taguchi J, Transplant
Ichinohe T, Yabe H, Morishima Y, Kato K,
Suzuki R, Fukuda T.

51(3):403
-9.

WGP
20-7

30(8):174
2-5.

WGP
20-8

174

Pre-transplant diabetes mellitus is a risk
Takano K, Fuji S, Uchida N, Ogawa H,
factor for non-relapse mortality, especially
Ohashi K, Eto T, Sakamaki H, Morishima
infection-related mortality, after allogeneic
Y, Kato K, Suzuki R, Fukuda T.
hematopoietic SCT.

Sinusoidal obstruction syndrome after
allogeneic hematopoietic stem cell175
transplantation: Incidence, risk factors andoutcomes.

Kato M, Yamashita T, Suzuki R,
Donor cell-derived hematologic
Matsumoto K, Nishimori H, Takahashi S,
176 malignancy: A survey by the Japan society Iwato K, Nakaseko C, Kondo T, Imada K,
for hematopoietic cell transplantation.
Kimura F, Ichinohe T, Hashii Y, Kato K,
Atsuta Y, Taniguchi S, Fukuda T.

Am J
Hematol

Leukemia

2016論文タイトル

Impact of total body irradiation on
successful neutrophil engraftment in
177
unrelated bone marrow or cord bloodtransplantation.

Clinical characteristics and outcome ofhuman herpesvirus-6 encephalitis after178
allogeneic hematopoietic stem celltransplantation.

著者

雑誌名

Nakasone H, Fuji S, Yakushijin K, Onizuka
M, Shinohara A, Ohashi K, Miyamura K,
Uchida N, Takanashi M, Ichinohe T,
Am J
Atsuta Y, Fukuda T, Ogata M;
Hematol
Complication Working Group of JapaneseSociety for Hematopoietic Cell
Transplantation.

刊・号・
頁

業績
番号

2017

92(2):171
-8.

WGP
20-9

Ogata M, Oshima K, Ikebe T, Takano K,
Kanamori H, Kondo T, Ueda Y, Mori T,
Hashimoto H, Ogawa H, Eto T, Ueki T,
Bone Marrow
2017
Miyamoto T, Ichinohe T, Atsuta Y, Fukuda Transplant
T.

Atsuta Y, Hirakawa A, Nakasone H,
Kurosawa S, Oshima K, Sakai R, Ohashi
K, Takahashi S, Mori T, Ozawa Y, Fukuda
Late Mortality and Causes of Death among
Biol Blood
T, Kanamori H, Morishima Y, Kato K, Yabe
179 Long-Term Survivors after Allogeneic
Marrow
H, Sakamaki H, Taniguchi S, Yamashita T;
Stem Cell Transplantation.
Transplant
Late Effect and Quality of Life Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Outcomes of patients who developed
180 subsequent solid cancer after
hematopoietic cell transplantation.

発行
年

Inamoto Y, Matsuda T, Tabuchi K,
Kurosawa S, Nakasone H, Nishimori H,
Yamasaki S, Doki N, Iwato K, Mori T,
Takahashi S, Yabe H, Kohno A, Nakamae
H, Sakura T, Hashimoto H, Sugita J, Ago
Blood
H, Fukuda T, Ichinohe T, Atsuta Y,
Advances
Yamashita T; Japan Society for
Hematopoietic Cell Transplantation Late
Effects and Quality of Life Working
Group.

52(11):15 WGP
63-70.
20-10

2016

22(9):170
2-9.

WGP
21-1

2018

2(15):190
1-13.

WGP
21-2